Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2005-07-26
2005-07-26
Wilson, James O. (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S045000, C514S047000, C536S027600, C536S027620, C536S027630, C536S027700, C536S055300
Reexamination Certificate
active
06921753
ABSTRACT:
The present invention relates to compounds of the formulaand pharmaceutically acceptable salts and solvates thereof, to processes for the preparation of, intermediates used in the preparation of, and compositions containing such compounds and the uses of such compounds as adenosine A2a receptor agonists.
REFERENCES:
patent: 6326359 (2001-12-01), Monaghan et al.
patent: 8803147 (1988-05-01), None
patent: 9111172 (1991-08-01), None
patent: 9402518 (1994-02-01), None
patent: 9407905 (1994-04-01), None
patent: 9602553 (1996-02-01), None
patent: 9855148 (1998-12-01), None
patent: 9924451 (1999-05-01), None
patent: 9934804 (1999-07-01), None
patent: 0023457 (2000-04-01), None
patent: 0077018 (2000-12-01), None
patent: 0127130 (2001-04-01), None
patent: 0127131 (2001-04-01), None
patent: 0160835 (2001-08-01), None
Jacobson, Kenneth A. et al., “Adenosine Receptors: Pharmacology, Structure-Activity Relationships, and Therapeutic Potential,” Journal of Medicinal Chemistry, 1992, 35 (3), 407-422.
Olsson, R. A. et al., “N6-substituted N-Alkyladenosine-5′-uronamides: Bifunctional Ligands Having Recognition Groups for A1 and A2 Adenosine Receptors,” Journal of Medicinal Chemistry, 1986, 29 (9), 1683-1689.
J. Med. Chem., 41, pp. 3174-3185 (1998).
J. Amer. Chem. Soc., 80, pp. 5168-5173 (1958).
J. Med. Chem., 12(1), pp. 9-15 (1969).
J. Org. Chem., 36(23), pp. 3539-3541 (1971).
Berge, et al.,J. Pharm. Sci., 66, pp. 1-19 (1977).
J. Amer. Chem. Soc., 105(10), pp. 3136-3147 (1983).
J. Med. Chem., 31(7), pp. 1282-1285 (1988).
Mantell Simon John
Monaghan Sandra Marina
Stephenson Peter Thomas
Benson Gregg C.
Henry Michael C.
Mulholland William F.
Pfizer Inc
Richardson Peter C.
LandOfFree
Purine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Purine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Purine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3373987